Newsletter | November 15, 2022

11.15.22 -- Five Questions That Determine The Success Of Your PROTAC Programs

Industry Insights
Five Questions That Determine The Success Of Your PROTAC Programs

Proteolysis-targeting chimeras (PROTACs) and other protein degradation strategies offer benefits in drug discovery for challenging targets. Discover considerations when launching a PROTAC development program.

Quality Matters: SEC Analysis For Antibody Aggregates

Size exclusion chromatography is the go-to analytical method for therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you can minimize column variation.

SPR Assays To Assess Similarity Between Innovator And Biosimilar Versions Of Nivolumab (Opdivo)

Learn more about developed and qualified SPR assays to characterize the binding and affinity of biosimilar and innovator nivolumab for all seven Fc gamma receptors, FcRn, and PD-1.

Crystallization Process Development: Ramping Up Bench-Scale Control

Since physical structure and biological activity are directly linked, controlling the physical form of a compound is paramount to a final drug product’s quality and effectiveness.

Combining Cell Clearance And Sterile Filtration Functionality For Improved Clarification Of Mammalian Cell Cultures

This application note demonstrates systems that have proven quite useful for clarification of mammalian cell cultures such as CHO-cells by combining the cell clearance and sterile filtration functionality in a single device.

Adapting To Change: API Custom Development And Manufacturing

A pharmaceutical company sought a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company, a molecule in clinical Phase 2/3 trials.

Successfully Producing Insoluble Proteins Using Inclusion Bodies

Lonza Pharma & Biotech’s Jonas Mueller and Nikolay Krumov answer attendee questions from a recent webinar about the pros and cons of soluble and insoluble processes as well as other related topics.

Solid Form Screening, Rapid Formulation Selection For Accelerated Timelines

See how experience, targeted testing, and basic scientific principles can quickly lead to the selection of effective and commercially viable formulations at an early stage of the development cycle.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.